Eisai to Present Abstracts on Oncology Products And Pipeline at 44th Annual San Antonio Breast Cancer Symposium Eisai Dec 06, 2021 11:30 HKT/SGT Read More
Olympus Selected for Inclusion in Dow Jones Sustainability World Index (DJSI World) Olympus Dec 02, 2021 14:00 HKT/SGT Read More
Eisai and FCNT Enter Into Business Alliance Aiming to Support People Living with Dementia and to Prevent Dementia Eisai Nov 30, 2021 09:13 HKT/SGT Read More
Eisai to Present Latest Data on Perampanel and E2730 at the 75th American Epilepsy Society Annual Meeting Eisai Nov 30, 2021 08:56 HKT/SGT Read More
European Commission Approves LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) for Patients With Certain Types of Endometrial Carcinoma Eisai Nov 29, 2021 11:44 HKT/SGT Read More
European Commission Approves LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) as First-Line Treatment for Adult Patients With Advanced Renal Cell Carcinoma Eisai Nov 29, 2021 09:15 HKT/SGT Read More
Transgene and NEC Announce Positive Preliminary Data from Phase I Studies of TG4050, a Novel Individualized Neoantigen Cancer Vaccine NEC Corporation Nov 23, 2021 10:14 HKT/SGT Read More
Hitachi Selected by the University of Tsukuba for its Second Proton Therapy System as a PFI Project Hitachi, Ltd. Nov 22, 2021 12:57 HKT/SGT Read More
エーザイ、社会的責任投資指数「Dow Jones Sustainability Asia Pacific Index」に8回目の選定 Eisai Nov 19, 2021 12:00 JST Read More
Eisai Receives the 'Most Liked!' IR Award at The 2021 IR Award Eisai Nov 18, 2021 14:28 HKT/SGT Read More
Eisai: New Phase 3 Data Show Positive Correlation Between ADUHELM Treatment Effect on Biomarkers and Reduction in Clinical Decline in Alzheimer's Disease Eisai Nov 12, 2021 15:10 HKT/SGT Read More
Eisai Presents New Analysis of Lecanemab Clinical Efficacy Results from Phase 2b Study at Clinical Trials On Alzheimer's Disease (CTAD) Conference Eisai Nov 12, 2021 14:31 HKT/SGT Read More
Eisai: Introduction of Plasma-based Biomarker Screening to Facilitate Identification of Subjects for Phase 3 Ahead 3-45 Trial Presented at Clinical Trials on Alzheimer's Disease (CTAD) Conference Eisai Nov 12, 2021 14:03 HKT/SGT Read More
